|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 586.00 CHF | +0.58% |
|
+2.06% | +8.96% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5.41B | 6.22B | 6.72B | 6.57B | 6.53B | |||||
Total Revenues | 5.41B | 6.22B | 6.72B | 6.57B | 6.53B | |||||
Cost of Goods Sold, Total | 3.3B | 3.78B | 4.31B | 4.16B | 4.18B | |||||
Gross Profit | 2.11B | 2.44B | 2.4B | 2.41B | 2.35B | |||||
Selling General & Admin Expenses, Total | 896M | 965M | 940M | 1.03B | 813M | |||||
R&D Expenses | 90M | 95M | 105M | 118M | 112M | |||||
Other Operating Expenses | 278M | -9M | -11M | 54M | 27M | |||||
Other Operating Expenses, Total | 1.26B | 1.05B | 1.03B | 1.2B | 952M | |||||
Operating Income | 846M | 1.39B | 1.37B | 1.21B | 1.4B | |||||
Interest Expense, Total | -81M | -69M | -100M | -147M | -168M | |||||
Interest And Investment Income | 3M | 6M | 46M | 40M | 43M | |||||
Net Interest Expenses | -78M | -63M | -54M | -107M | -125M | |||||
Income (Loss) On Equity Invest. | -28M | 2M | -13M | -1M | 2M | |||||
Currency Exchange Gains (Loss) | -7M | -15M | -6M | 20M | -16M | |||||
Other Non Operating Income (Expenses) | -4M | -8M | -8M | -85M | -5M | |||||
EBT, Excl. Unusual Items | 729M | 1.3B | 1.29B | 1.04B | 1.25B | |||||
Restructuring Charges | 8M | - | -50M | -54M | -47M | |||||
Merger & Related Restructuring Charges | - | - | - | -166M | -12M | |||||
Impairment of Goodwill | - | - | - | -16M | - | |||||
Gain (Loss) On Sale Of Investments | 27M | -4M | -2M | -5M | -16M | |||||
Gain (Loss) On Sale Of Assets | -3M | 194M | -1M | 80M | -6M | |||||
Asset Writedown | - | -2M | -439M | -92M | -94M | |||||
Legal Settlements | -1M | -38M | - | - | - | |||||
Other Unusual Items | - | -5M | -6M | -31M | 23M | |||||
EBT, Incl. Unusual Items | 760M | 1.45B | 790M | 754M | 1.1B | |||||
Income Tax Expense | 83M | 230M | 135M | 117M | 192M | |||||
Earnings From Continuing Operations | 677M | 1.22B | 655M | 637M | 909M | |||||
Earnings Of Discontinued Operations | 2.27B | - | - | - | -1.18B | |||||
Net Income to Company | 2.95B | 1.22B | 655M | 637M | -275M | |||||
Minority Interest | -3M | -3M | -1M | -1M | - | |||||
Net Income - (IS) | 2.94B | 1.22B | 654M | 636M | -275M | |||||
Net Income to Common Incl Extra Items | 2.94B | 1.22B | 654M | 636M | -275M | |||||
Net Income to Common Excl. Extra Items | 674M | 1.22B | 654M | 636M | 909M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 39.65 | 16.37 | 8.88 | 8.94 | -3.93 | |||||
Basic EPS - Continuing Operations | 9.08 | 16.37 | 8.88 | 8.94 | 12.98 | |||||
Basic Weighted Average Shares Outstanding | 74.26M | 74.23M | 73.63M | 71.18M | 70.02M | |||||
Net EPS - Diluted | 39.52 | 16.34 | 8.88 | 8.92 | -3.93 | |||||
Diluted EPS - Continuing Operations | 9.05 | 16.34 | 8.88 | 8.92 | 12.98 | |||||
Diluted Weighted Average Shares Outstanding | 74.49M | 74.36M | 73.68M | 71.29M | 70.02M | |||||
Normalized Basic EPS | 6.1 | 10.93 | 10.92 | 9.1 | 11.18 | |||||
Normalized Diluted EPS | 6.08 | 10.91 | 10.91 | 9.09 | 11.18 | |||||
Dividend Per Share | 3 | 3.5 | 4 | 4 | 5 | |||||
Payout Ratio | 7.57 | 18.35 | 39.76 | 44.81 | -101.82 | |||||
American Depositary Receipts Ratio (ADR) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.31B | 1.9B | 1.92B | 1.79B | 2.14B | |||||
EBITA | 996M | 1.54B | 1.51B | 1.36B | 1.56B | |||||
EBIT | 846M | 1.39B | 1.37B | 1.21B | 1.4B | |||||
EBITDAR | 1.33B | 1.93B | 1.94B | 1.82B | 2.16B | |||||
Effective Tax Rate - (Ratio) | 10.92 | 15.88 | 17.09 | 15.52 | 17.44 | |||||
Total Current Taxes | 126M | 211M | 184M | 129M | 122M | |||||
Total Deferred Taxes | -43M | 19M | -49M | -12M | 70M | |||||
Normalized Net Income | 453M | 811M | 804M | 648M | 783M | |||||
Interest on Long-Term Debt | 17M | 17M | 20M | 19M | 19M | |||||
Non-Cash Pension Expense | 1M | -9M | 1M | 1M | 1M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 224M | 244M | 237M | 259M | 190M | |||||
General and Administrative Expenses | 671M | 721M | 702M | 768M | 622M | |||||
Research And Development Expense From Footnotes | 185M | 186M | 194M | 206M | 198M | |||||
Net Rental Expense, Total | 20M | 29M | 30M | 35M | 25M | |||||
Imputed Operating Lease Interest Expense | 3.95M | 6M | 8.39M | 9.81M | 6.78M | |||||
Imputed Operating Lease Depreciation | 16.05M | 23M | 21.61M | 25.19M | 18.22M | |||||
Stock-Based Comp., Other (Total) | 45M | 32M | 21M | 41M | 57M | |||||
Total Stock-Based Compensation | 45M | 32M | 21M | 41M | 57M |
- Stock Market
- Stocks
- LONN Stock
- Financials Lonza Group AG
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















